Bli medlem
Bli medlem

Du är här


CellaVision AB: Notice of 2015 Annual General Meeting in CellaVision AB

The shareholders in CellaVision AB are hereby summoned to the Annual General
Meeting, to be held on May 6, 2015 at 16.00 at CellaVision AB, Scheelevägen
19 A, Ideon, in Lund, Sweden.

The complete notice is available in Swedish only.

For more information, please contact:

Zlatko Rihter, CEO, CellaVision AB

Phone:+46 733 62 11 06|

About CellaVision

CellaVision is an innovative, global medical technology company that develops
and sells its own leading systems for routine analysis of blood and other
body fluids in health care services. The analyses often constitute important
reference data for fast and correct diagnosis of illnesses, for example of
infections and serious cancers. CellaVision's products rationalize manual
laboratory work, and secure and support effective workflows and skills
development within and between hospitals. The company has leading-edge
expertise in image analysis, artificial intelligence and automated
microscopy. In 2014 sales were SEK 217 million and sales continue to
increase, with a growth target of at least 15 % per year over an economic
cycle. CellaVision's registered office is in Lund and the company has
subsidiaries in the USA, Canada and Japan. The share is listed on the Nasdaq
OMX Stockholm, Small Cap list. Read more

Notice of 2015 Annual General Meeting in CellaVision AB (Swedish)


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: CellaVision AB via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.